Insider Transactions in Q4 2022 at Kiniksa Pharmaceuticals, Ltd. (KNSA)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 29
2022
|
Barry D Quart |
SELL
Open market or private sale
|
Direct |
21,959
-100.0%
|
$351,344
$16.15 P/Share
|
|
Nov 29
2022
|
Barry D Quart |
BUY
Exercise of conversion of derivative security
|
Direct |
21,959
+50.0%
|
$21,959
$1.59 P/Share
|
|
Nov 07
2022
|
John F. Paolini CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
28,357
-43.83%
|
$425,355
$15.18 P/Share
|
|
Nov 07
2022
|
John F. Paolini CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
28,357
+30.48%
|
$28,357
$1.86 P/Share
|
|
Oct 04
2022
|
Michael R Megna CHIEF ACCOUNTING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
52
-0.7%
|
$728
$14.23 P/Share
|
|
Oct 04
2022
|
Michael R Megna CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
175
+2.29%
|
-
|